{"transactions":[{"id":693065,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-07T20:19:06.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a grant of options to purchase ordinary shares. This grant of options was originally approved by the Board on July 15, 2022, subject to (i) approval by the Company's shareholders, which was obtained on September 7, 2022, (ii) the occurrence of a Triggering Event (as defined and specified in Ms. Toledano's employment agreement), which was satisfied upon the Company obtaining the necessary resources to fund its Phase 3 trial through the consummation of the Company's July 2026 financing transaction, and (iii) the filing by the Company of a Registration Statement on Form S-8 registering the ordinary shares underlying the option grant, which occurred on August 7, 2026. The options vest over a four-year period that commenced on August 7, 2026, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period."}],"balance_after":200000,"derivative":{"exercise_price":2.81,"expiration_date":"2036-08-07","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001178913-26-003950","document":"zk2635792.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891326003950/zk2635792.xml","form_type":"4"}},{"id":693064,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-07T20:19:06.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a grant of options to purchase ordinary shares. This grant of options was approved by the Board of Directors (the \"Board\") of Entera Bio Ltd. (the \"Company\") on May 7, 2026, subject to (i) approval by the Company's shareholders, which was obtained on July 14, 2026 and (ii) the filing by the Company of a Registration Statement on Form S-8 registering the ordinary shares underlying the option grant, which occurred on August 7, 2026. The options vest over a three year period which began on May 7, 2026, with one third of the options vesting on May 7, 2027 and the remaining two-thirds vesting ratably on a quarterly basis over the remaining two-year period, subject to full acceleration upon a Change in Control (as defined in the Company's 2018 Equity Incentive Plan (the \"Plan\"))."}],"balance_after":500000,"derivative":{"exercise_price":1.37,"expiration_date":"2036-05-06","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001178913-26-003950","document":"zk2635792.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891326003950/zk2635792.xml","form_type":"4"}},{"id":708047,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2026-07-16T20:05:27.000Z","date":"2026-07-14","kind":"grant","planned":false,"acquired":true,"shares":72993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board on May 7, 2026, subject to approval by the Company's shareholders, which was obtained on July 14, 2026. This grant was awarded to the Reporting Person in lieu of $100,000 the Reporting Person is entitled to under the Reporting Person's base salary for 2026. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on May 1, 2026, subject to full acceleration upon a Change in Control (as defined in the Plan)."}],"balance_after":847135,"source":{"system":"sec-edgar","filing":"0001178913-26-003508","document":"zk2635690.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891326003508/zk2635690.xml","form_type":"4"}},{"id":708046,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2026-07-16T20:05:27.000Z","date":"2026-07-14","kind":"grant","planned":false,"acquired":true,"shares":347567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the \"Board\") of Entera Bio Ltd. (the \"Company\") on May 7, 2026, subject to approval by the Company's shareholders, which was obtained on July 14, 2026. This grant was awarded to the Reporting Person in lieu of the Reporting Person's 2025 annual cash bonus. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on May 1, 2026, subject to full acceleration upon a Change in Control (as defined in the Company's 2018 Equity Incentive Plan (the \"Plan\"))."}],"balance_after":774142,"source":{"system":"sec-edgar","filing":"0001178913-26-003508","document":"zk2635690.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891326003508/zk2635690.xml","form_type":"4"}},{"id":717998,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-07-02T20:07:30.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":168618,"source":{"system":"sec-edgar","filing":"0001104659-26-080320","document":"tm2619538-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465926080320/tm2619538-3_4seq1.xml","form_type":"4"}},{"id":723986,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-06-29T20:05:16.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":118618,"source":{"system":"sec-edgar","filing":"0001104659-26-078817","document":"tm2619089-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465926078817/tm2619089-3_4seq1.xml","form_type":"4"}},{"id":957204,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2025-12-30T11:01:25.000Z","date":"2025-12-29","kind":"purchase","planned":false,"acquired":true,"shares":11000,"price":1.8102,"value":19912.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.75 to $1.82, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company (\"Entera Bio\"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":426575,"source":{"system":"sec-edgar","filing":"0001178913-25-004125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891325004125/ownership.xml","form_type":"4"}},{"id":1072219,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-08-07T21:16:13.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 5, 2025, the reporting person was granted 20,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029 and 6,666 shares on August 5, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":108618,"source":{"system":"sec-edgar","filing":"0001104659-25-075266","document":"tm2522819-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465925075266/tm2522819-3_4seq1.xml","form_type":"4"}},{"id":1084675,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-18T20:37:05.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This grant of options was approved by the Board on April 28, 2025, subject to approval by the Company's shareholders, which was obtained on July 16, 2025. The options vest over a three-year period that commenced on April 28, 2025, with a third of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period."}],"balance_after":500000,"derivative":{"exercise_price":2.28,"expiration_date":"2035-04-28","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001178913-25-002414","document":"zk2533456.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891325002414/zk2533456.xml","form_type":"4"}},{"id":1084674,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2025-07-18T20:37:05.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":43860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board on April 28, 2025, subject to approval by the Company's shareholders, which was obtained on July 16, 2025. This grant was awarded to the Reporting Person in lieu of $100,000 the Reporting Person is entitled to under the Reporting Person's base salary for 2025. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 1, 2025."}],"balance_after":415575,"source":{"system":"sec-edgar","filing":"0001178913-25-002414","document":"zk2533456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891325002414/zk2533456.xml","form_type":"4"}},{"id":1084673,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2025-07-18T20:37:05.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":136842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the \"Board\") of Entera Bio Ltd. (the \"Company\") on April 28, 2025, subject to approval by the Company's shareholders, which was obtained on July 16, 2025. This grant was awarded to the Reporting Person in lieu of the Reporting Person's 2024 annual cash bonus. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 28, 2025."}],"balance_after":371715,"source":{"system":"sec-edgar","filing":"0001178913-25-002414","document":"zk2533456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891325002414/zk2533456.xml","form_type":"4"}},{"id":1091276,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-07-08T01:50:54.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":7173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2025, the reporting person was granted 7,173 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in full on June 25, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":88618,"source":{"system":"sec-edgar","filing":"0001104659-25-066240","document":"tm2520050-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465925066240/tm2520050-5_4seq1.xml","form_type":"4"}},{"id":1442919,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-02T20:30:44.000Z","date":"2024-07-31","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant of options was approved by the Board on April 19, 2024, subject to approval by the Company's shareholders, which was obtained on July 31, 2024. The options vest over a three-year period that commenced on April 19, 2024, with a third of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period."}],"balance_after":500000,"derivative":{"exercise_price":1.99,"expiration_date":"2034-04-19","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001178913-24-002391","document":"zk2431765.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891324002391/zk2431765.xml","form_type":"4"}},{"id":1442918,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2024-08-02T20:30:44.000Z","date":"2024-07-31","kind":"grant","planned":false,"acquired":true,"shares":124121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the \"Board\") of Entera Bio Ltd. (the \"Company\") on April 19, 2024, subject to approval by the Company's shareholders, which was obtained on July 31, 2024. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 19, 2024."}],"balance_after":234873,"source":{"system":"sec-edgar","filing":"0001178913-24-002391","document":"zk2431765.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891324002391/zk2431765.xml","form_type":"4"}},{"id":1456931,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-07-10T20:45:06.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":9728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 8, 2024, the reporting person was granted 9,728 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 8, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":81445,"source":{"system":"sec-edgar","filing":"0001104659-24-078970","document":"tm2419199-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465924078970/tm2419199-2_4seq1.xml","form_type":"4"}},{"id":1699505,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants (right to buy)","published_at":"2023-12-27T13:27:29.000Z","date":"2023-12-22","kind":"purchase","planned":false,"acquired":true,"shares":23952,"price":0.125,"value":2994.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person entered into a Securities Purchase Agreement with the Issuer on December 20, 2023, pursuant to which, on December 22, 2023, the Reporting Person acquired an aggregate of 23,952 units for a purchase price of $0.835 per unit, each unit consisting of one share of the Issuer's ordinary shares, par value NIS 0.0000769 per share (\"Ordinary Shares\"), and one warrant, exercisable to purchase an Ordinary Share at an exercise price of $1.00 per share. The purchase price for each unit included $0.125 for the warrant in accordance with Nasdaq rules."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person entered into a Securities Purchase Agreement with the Issuer on December 20, 2023, pursuant to which, on December 22, 2023, the Reporting Person acquired an aggregate of 23,952 units for a purchase price of $0.835 per unit, each unit consisting of one share of the Issuer's ordinary shares, par value NIS 0.0000769 per share (\"Ordinary Shares\"), and one warrant, exercisable to purchase an Ordinary Share at an exercise price of $1.00 per share. The purchase price for each unit included $0.125 for the warrant in accordance with Nasdaq rules."}],"balance_after":23952,"derivative":{"exercise_price":1,"exercise_date":"2023-12-22","expiration_date":"2028-12-22","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":23952},"source":{"system":"sec-edgar","filing":"0001178913-23-003971","document":"zk2330699.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891323003971/zk2330699.xml","form_type":"4"}},{"id":1699504,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2023-12-27T13:27:29.000Z","date":"2023-12-22","kind":"purchase","planned":false,"acquired":true,"shares":23952,"price":0.71,"value":17005.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person entered into a Securities Purchase Agreement with the Issuer on December 20, 2023, pursuant to which, on December 22, 2023, the Reporting Person acquired an aggregate of 23,952 units for a purchase price of $0.835 per unit, each unit consisting of one share of the Issuer's ordinary shares, par value NIS 0.0000769 per share (\"Ordinary Shares\"), and one warrant, exercisable to purchase an Ordinary Share at an exercise price of $1.00 per share. The purchase price for each unit included $0.125 for the warrant in accordance with Nasdaq rules."}],"balance_after":110752,"source":{"system":"sec-edgar","filing":"0001178913-23-003971","document":"zk2330699.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891323003971/zk2330699.xml","form_type":"4"}},{"id":1781059,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-14T21:02:48.000Z","date":"2023-09-13","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This grant of options was approved by the Board of Directors (the \"Board\") of Entera Bio Ltd. (the \"Company\") on April 24, 2023, subject to approval by the Company's shareholders, which was obtained on September 13, 2023. The options vest over a four-year period that commenced on April 24, 2023, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period."}],"balance_after":350000,"derivative":{"exercise_price":0.795,"expiration_date":"2033-04-24","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001178913-23-003156","document":"zk2330299.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891323003156/zk2330299.xml","form_type":"4"}},{"id":1800784,"issuer":{"id":8400,"kind":"organization","name":"NEXGEL, INC."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-21T20:34:17.000Z","date":"2023-08-17","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options granted pursuant to the Issuer's 2019 Long-Term Incentive Plan, as amended, for past services as a member of the Issuer's Board of Directors. The total number of shares vested as of August 17, 2023."}],"balance_after":15000,"derivative":{"exercise_price":2.05,"exercise_date":"2023-08-17","expiration_date":"2033-08-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-23-029652","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000149315223029652/ownership.xml","form_type":"4"}},{"id":1823514,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-07-25T20:06:06.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":27472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2023, the reporting person was granted 27,472 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,717 restricted stock units, 27,472 of which will vest in full on July 21, 2024 as set forth in footnote 1, and 10,000 units of which will vest on July 1, 2024."}],"balance_after":71717,"source":{"system":"sec-edgar","filing":"0001104659-23-083831","document":"tm2321950-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465923083831/tm2321950-4_4seq1.xml","form_type":"4"}},{"id":1923795,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2023-04-06T20:05:43.000Z","date":"2023-04-04","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":1.01,"value":30300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4976 to $0.55, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company (\"Entera Bio\"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":86800,"source":{"system":"sec-edgar","filing":"0001178913-23-001348","document":"zk2329512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891323001348/zk2329512.xml","form_type":"4"}},{"id":2117996,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2022-11-14T14:13:25.000Z","date":"2022-11-11","kind":"purchase","acquired":true,"shares":50000,"price":0.5317,"value":26585.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4976 to $0.55, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company (\"Entera Bio\"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":56800,"source":{"system":"sec-edgar","filing":"0001178913-22-003988","document":"zk2228743.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891322003988/zk2228743.xml","form_type":"4"}},{"id":2162323,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-09T20:07:28.000Z","date":"2022-09-07","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant of options was approved by the Board on July 15, 2022, subject to approval by the Company's shareholders, which was obtained on September 7, 2022. The options vest over a four-year period that commenced on July 15, 2022, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period."}],"balance_after":600000,"derivative":{"exercise_price":1.4,"expiration_date":"2032-07-15","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001178913-22-003372","document":"zk2227078.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891322003372/zk2227078.xml","form_type":"4"}},{"id":2162322,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-09T20:07:28.000Z","date":"2022-09-07","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This grant of options was approved by the Board of Directors (the \"Board\") of Entera Bio Ltd. (the \"Company\") on May 11, 2022, subject to approval by the Company's shareholders, which was obtained on September 7, 2022. The options vest over a four-year period that commenced on May 16, 2022, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period."}],"balance_after":500000,"derivative":{"exercise_price":2.02,"expiration_date":"2032-05-16","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001178913-22-003372","document":"zk2227078.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891322003372/zk2227078.xml","form_type":"4"}},{"id":2202814,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-25T13:35:20.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":14245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2022, the reporting person was granted 14,245 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 34,245 restricted stock units, 14,245 of which will vest as set forth in footnote 1, and 20,000 of which will vest in increments as follows: (1) 10,000 units on July 1, 2023, and (2) 10,000 units on July 1, 2024."}],"balance_after":44245,"source":{"system":"sec-edgar","filing":"0001104659-22-082287","document":"tm2221508-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465922082287/tm2221508-3_4seq1.xml","form_type":"4"}},{"id":2308339,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2022-04-04T20:49:49.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 restricted stock units relating to this grant will vest in three increments as follows: (1) 10,000 units on July 1, 2022, (2) 10,000 units on July 1, 2023, and (3) 10,000 units on July 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods as set forth in footnote 1."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001104659-22-042282","document":"tm2211324-11_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465922042282/tm2211324-11_4.xml","form_type":"4"}},{"id":2432324,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2022-01-19T21:04:52.000Z","date":"2022-01-14","kind":"purchase","acquired":true,"shares":6800,"price":2.7899,"value":18971.32,"ownership":{"direct":true},"balance_after":6800,"source":{"system":"sec-edgar","filing":"0001178913-22-000165","document":"zk2227078.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891322000165/zk2227078.xml","form_type":"4"}},{"id":2437771,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-11T21:12:11.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":107557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest ratably on a quarterly basis over a three-year period that commenced on January 1, 2022."}],"balance_after":107557,"derivative":{"exercise_price":2.815,"expiration_date":"2032-01-01","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":107557},"source":{"system":"sec-edgar","filing":"0001178913-22-000095","document":"zk2227047.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891322000095/zk2227047.xml","form_type":"4"}},{"id":2437770,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-11T21:12:11.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":35852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2022."}],"balance_after":35852,"derivative":{"exercise_price":2.815,"expiration_date":"2032-01-01","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":35852},"source":{"system":"sec-edgar","filing":"0001178913-22-000095","document":"zk2227047.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000117891322000095/zk2227047.xml","form_type":"4"}},{"id":2454320,"issuer":{"id":8400,"kind":"organization","name":"NEXGEL, INC."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2022-01-03T21:45:48.000Z","date":"2021-12-27","kind":"grant","acquired":true,"shares":1819,"price":0.01,"value":18.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired the shares of common stock and warrant to purchase common stock reported on this Form 4 in connection with the Issuer's underwritten public offering which closed on December 27, 2021."}],"balance_after":1819,"derivative":{"exercise_price":5.5,"exercise_date":"2021-12-27","expiration_date":"2026-12-26","underlying":"Common Stock","underlying_shares":1819},"source":{"system":"sec-edgar","filing":"0001104659-22-000437","document":"tm221361-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465922000437/tm221361-4_4seq1.xml","form_type":"4"}},{"id":2454319,"issuer":{"id":8400,"kind":"organization","name":"NEXGEL, INC."},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-03T21:45:48.000Z","date":"2021-12-27","kind":"purchase","acquired":true,"shares":1819,"price":5.49,"value":9986.31,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The Reporting Person acquired the shares of common stock and warrant to purchase common stock reported on this Form 4 in connection with the Issuer's underwritten public offering which closed on December 27, 2021."}],"balance_after":1819,"source":{"system":"sec-edgar","filing":"0001104659-22-000437","document":"tm221361-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686530/000110465922000437/tm221361-4_4seq1.xml","form_type":"4"}},{"id":2651863,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-29T18:31:38.000Z","date":"2021-06-25","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option has a term of 10 years and vest in equal monthly installments over the 48 month period commencing on July 25, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The option has a term of 10 years and vest in equal monthly installments over the 48 month period commencing on July 25, 2021."}],"balance_after":50000,"derivative":{"exercise_price":4.9,"underlying":"Common Stock, $.0001 Par Value","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001686530-21-000006","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000168653021000006/edgar.xml","form_type":"4"}},{"id":2651862,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":25436,"kind":"person","name":"Toledano Miranda Jayne","position":1,"cik":"0001686530","reported_name":"Toledano Miranda Jayne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 Par Value","published_at":"2021-06-29T18:31:38.000Z","date":"2021-06-25","kind":"other","acquired":true,"shares":1791549,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person acquired 1,791,549 shares of the issuer's common stock as consideration in connection with the acquisition of TRIGR Therapeutics, Inc. by the issuer. The merger agreement, which was entered into on May 13, 2021, placed a negotiated value on the issuer's common stock of $5.85 a share. Of the 1,791,549 shares issued to the reporting person in the merger, 283,648 shares are currently being held in escrow and are subject to forfeiture for the purposes described in the merger agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired 1,791,549 shares of the issuer's common stock as consideration in connection with the acquisition of TRIGR Therapeutics, Inc. by the issuer. The merger agreement, which was entered into on May 13, 2021, placed a negotiated value on the issuer's common stock of $5.85 a share. Of the 1,791,549 shares issued to the reporting person in the merger, 283,648 shares are currently being held in escrow and are subject to forfeiture for the purposes described in the merger agreement."}],"balance_after":1791549,"source":{"system":"sec-edgar","filing":"0001686530-21-000006","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738021/000168653021000006/edgar.xml","form_type":"4"}}]}